financetom
Business
financetom
/
Business
/
Dorman Products Q3 Adjusted EPS, Revenue Up; 2024 Guidance Raised -- Shares Jump After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dorman Products Q3 Adjusted EPS, Revenue Up; 2024 Guidance Raised -- Shares Jump After Hours
Nov 4, 2024 11:46 AM

05:26 PM EDT, 10/31/2024 (MT Newswires) -- Dorman Products ( DORM ) reported Q3 adjusted earnings late Thursday of $1.96 per diluted share, up from $1.40 a year earlier.

Analysts polled by Capital IQ expected $1.53.

Net sales for the quarter ended Sept. 28 were $503.8 million, up from $488.2 million a year earlier.

Analysts surveyed by Capital IQ expected $509.5 million.

The company raised its 2024 adjusted EPS guidance to $6.85 to $6.95 from $6.00 to $6.20. Analysts polled by Capital IQ expect $6.14.

Net sales growth for the year is projected to be between 3.5% to 4.5% from a year ago, as opposed to previous guidance of 3% to 5%. Analysts polled by Capital IQ expect revenue of $2 billion.

Shares were up 4% in recent after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US retailers split on holiday prospects amid consumer caution
US retailers split on holiday prospects amid consumer caution
Aug 20, 2025
(Reuters) -Mixed sales and profit forecasts from major U.S. retailers such as Target and Home Depot have prompted investors to question if this year's crucial holiday season will yield the windfall typically associated with a year-end shopping surge. Rising costs driven by U.S. President Donald Trump's import tariffs and subdued consumer spending have given rise to fresh worries about the...
Regeneron Pharmaceuticals Says FDA Extends Action Dates for Eylea HD to Q4
Regeneron Pharmaceuticals Says FDA Extends Action Dates for Eylea HD to Q4
Aug 20, 2025
11:44 AM EDT, 08/20/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday the US Food and Drug Administration has extended the target action dates of two Eylea HD injection regulatory submissions to Q4. The FDA extended the review periods due to information from a recent inspection of a third-party manufacturer, which it determined was a major amendment to...
Home Depot's Q2 Results Signal 'Outsized Gains' as Recovery Takes Shape, UBS Says
Home Depot's Q2 Results Signal 'Outsized Gains' as Recovery Takes Shape, UBS Says
Aug 20, 2025
11:44 AM EDT, 08/20/2025 (MT Newswires) -- Home Depot's ( HD ) Q2 results provided evidence that the company should see outsized gains as a recovery takes shape, UBS said in a Tuesday note. UBS said it viewed Home Depot's ( HD ) Q2 comparable sales growth of 1% as an indication that customers were still engaging with smaller home...
U.S. Senator Sanders favors Trump plan to take stake in Intel
U.S. Senator Sanders favors Trump plan to take stake in Intel
Aug 20, 2025
WASHINGTON, Aug 20 (Reuters) - Liberal U.S. Senator Bernie Sanders on Wednesday threw his support behind Republican President Donald Trump's plan to convert up to $10.9 billion in U.S. grants for Intel ( INTC ) into a government stake in the company. If microchip companies make a profit from the generous grants they receive from the federal government, the taxpayers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved